Big Pharma racism? Why new Alzheimer's drug works better for White than Black Americans

Researchers revealed that older Black Americans, who have twice the rate of dementia compared to whites were excluded from clinical trials of these drugs

Related Keywords

Irvine ,California ,United States ,Tokyo ,Japan ,Chicago ,Illinois ,Americans ,Shobha Dhadda ,Eli Lilly ,Reisa Sperling ,Lisa Barnes ,Mark Mintun ,Ivan Cheung ,National Institutes Of Health ,Rush Alzheimer Disease Research Center ,Reuters ,Drug Administration ,University Of California ,Rush Center ,Black Americans ,Rush Alzheimer ,Disease Research Center ,African Americans ,National Institutes ,Nature Reviews Neurology ,Joshua Grill , ,